leflunomid "egis" 10 mg filmovertrukne tabletter
egis pharmaceuticals plc - leflunomid - filmovertrukne tabletter - 10 mg
leflunomid "egis" 15 mg filmovertrukne tabletter
egis pharmaceuticals plc - leflunomid - filmovertrukne tabletter - 15 mg
leflunomid "egis" 20 mg filmovertrukne tabletter
egis pharmaceuticals plc - leflunomid - filmovertrukne tabletter - 20 mg
leflunomid "pharmathen" 15 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 15 mg
leflunomid "pharmathen" 20 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 20 mg
aubagio
sanofi winthrop industrie - teriflunomide - multipel sclerose - selektive immunosuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressants, selektiv immunosuppressive - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomide "sandoz" 14 mg filmovertrukne tabletter
sandoz a/s - teriflunomid - filmovertrukne tabletter - 14 mg
methotrexat "accord" 25 mg/ml injektionsvæske, opløsning
accord healthcare b.v. - methotrexat - injektionsvæske, opløsning - 25 mg/ml